Business Context and Reporting Period
This Form 8-K is a current report filed by Intelligent Bio Solutions Inc. (INBS) on January 6, 2025, covering events occurring as of January 2, 2025. The company is incorporated in Delaware and trades on The Nasdaq Stock Market LLC. It is classified as an emerging growth company.
Key Financial Metrics
The filing does not provide specific financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The report focuses exclusively on capital structure updates regarding share counts.
Material Changes
The primary material change reported is an increase in the total number of outstanding shares of common stock due to two specific transactions:
- At The Market Offering: Sale of shares pursuant to an agreement dated September 18, 2024, with Ladenburg Thalmann & Co. Inc.
- Restricted Stock Issuance: Issuance of 8,109 shares of restricted common stock pursuant to an Investor Relations and Corporate Development Advisory Agreement dated February 29, 2024, with ClearThink Capital Partners LLC.
As a result of these activities, the total outstanding common stock as of the close of business on January 2, 2025, is 4,807,068 shares.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, outlook, or discussion of risks and contingencies beyond the disclosure of the share issuance events.
Investor Verification Checklist
- Verify the exact number of shares sold under the At The Market Offering Agreement to reconcile the total share count increase.
- Confirm the valuation and terms of the 8,109 restricted shares issued to ClearThink Capital Partners LLC.
- Review the September 18, 2024, At The Market Offering Agreement for any remaining capacity or pricing constraints.